Home

Innere leichtsinnig Verschiebung ioannis trougakos Habe gedacht MwSt bevorzugen

Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research  Foundation | LinkedIn
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn

Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive  Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection  | Immunology
Frontiers | Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection | Immunology

Loop | Ioannis Trougakos
Loop | Ioannis Trougakos

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast  cancer patients receiving CDK4/6 inhibitors - The Breast
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors - The Breast

Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research  Foundation | LinkedIn
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn

Olive Bioactives: applications and prospects | LE STUDIUM
Olive Bioactives: applications and prospects | LE STUDIUM

Identification of new biomarkers and therapeutic targets for MDR tumours -  Stratagem
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem

6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor,  activates cytoprotective cellular modules and suppresses cellular  senescence-mediated biomolecular damage in human fibroblasts | Scientific  Reports
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts | Scientific Reports

Ioannis P. Trougakos's research works | National and Kapodistrian  University of Athens, Athens (uoa) and other places
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places

Identification of new biomarkers and therapeutic targets for MDR tumours -  Stratagem
Identification of new biomarkers and therapeutic targets for MDR tumours - Stratagem

Tweets with replies by Jean-Michel Escoffre (@JMEscoffre31) / Twitter
Tweets with replies by Jean-Michel Escoffre (@JMEscoffre31) / Twitter

Ioannis Trougakos
Ioannis Trougakos

Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy  individuals with prior asymptomatic versus clinical infection | medRxiv
Blood transcriptomes of anti-SARS-CoV2 antibody positive healthy individuals with prior asymptomatic versus clinical infection | medRxiv

Home
Home

Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research  Foundation | LinkedIn
Ph.D. Ioannis P Trougakos - Research Lecturer - National Hellenic Research Foundation | LinkedIn

Third Dose of the BNT162b2 Vaccine Results in Very High Levels of  Neutralizing Antibodies Against SARS‐CoV‐2; Results of a Prospective Study  in 150 Health Professionals in Greece - Terpos - - American
Third Dose of the BNT162b2 Vaccine Results in Very High Levels of Neutralizing Antibodies Against SARS‐CoV‐2; Results of a Prospective Study in 150 Health Professionals in Greece - Terpos - - American

Ioannis Trougakos * - AD Scientific Index 2022
Ioannis Trougakos * - AD Scientific Index 2022

Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after  BNT162b2 vaccination in patients with amyloidosis and the impact of therapy  - Kastritis - - American Journal of Hematology - Wiley Online Library
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective  immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients,Cell  Reports - X-MOL
Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients,Cell Reports - X-MOL

University of Athens | Tascmar
University of Athens | Tascmar

Ioannis P. Trougakos's research works | National and Kapodistrian  University of Athens, Athens (uoa) and other places
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places

Greece – Mu.Ta.Lig – COST ACTION CA15135
Greece – Mu.Ta.Lig – COST ACTION CA15135

Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual  Laboratory
Cardiotoxicity Due to Proteasome Dysfunction | Bioimaging-GR, Virtual Laboratory

Ioannis P. Trougakos's research works | National and Kapodistrian  University of Athens, Athens (uoa) and other places
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places

Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and  neutralizing antibodies in convalescent and naïve recipients of the  BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text
Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients | BMC Medicine | Full Text

Ioannis P. Trougakos's research works | National and Kapodistrian  University of Athens, Athens (uoa) and other places
Ioannis P. Trougakos's research works | National and Kapodistrian University of Athens, Athens (uoa) and other places

CHUNLONG CHEN | Institut Curie
CHUNLONG CHEN | Institut Curie

The Speakers – ICSA 2019 Athens
The Speakers – ICSA 2019 Athens